Document is current
Any future updates will be listed below
-
Authors
Farley, Clara R.
Irwin, Shelby
Adesoye, Taiwo
Sun, Susie X.
DeSnyder, Sarah M.
Lucci, Anthony
Shaitelman, Simona F.
Chang, Edward I.
Ueno, Naoto T.
Woodward, Wendy A.
Teshome, Mediget
-
Funding
Funding for this research was provided by:
State of Texas Rare and Aggressive Breast Cancer Research Program Grant
Morgan Welch Inflammatory Breast Cancer Research Program
- License Information
-
More Information
Article History
Received: 31 March 2022
Accepted: 16 June 2022
First Online: 19 July 2022
Disclosures
: Simona Shaitelman discloses the following relationships: Alpha Tau (Contracted research agreement), Artios Pharma, Emerson Collective, Exact Sciences (Contracted research agreement), NIH R21, TAE Life Sciences (Contracted research agreement). Wendy Woodward discloses the following relationships: Exact Sciences (honoraria), DOD (contracted research agreement), Susan G. Komen (contracted research agreement, NIH R-01, Epic Science (honoraria). All other authors have reported no financial disclosures.
